国际医学
(000516)
| 流通市值：117.66亿 | | | 总市值：119.57亿 |
| 流通股本：22.24亿 | | | 总股本：22.60亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 427,482,946.42 | 667,259,133.82 | 742,163,400.11 | 943,962,638.82 |
| 应收票据及应收账款 | 753,350,686.68 | 657,946,126.8 | 647,218,042.92 | 661,684,668.02 |
| 应收账款 | 753,350,686.68 | 657,946,126.8 | 647,218,042.92 | 661,684,668.02 |
| 预付款项 | 11,988,100.36 | 14,035,181.8 | 8,269,078.74 | 6,869,617.24 |
| 其他应收款合计 | 52,521,289.37 | 45,885,343.04 | 50,792,987.07 | 44,469,071.14 |
| 存货 | 98,559,720.86 | 74,474,137.08 | 75,929,958.16 | 78,336,971.7 |
| 其他流动资产 | 45,185,154.8 | 46,614,264.75 | 46,642,014.69 | 41,131,522.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,461,576,314.49 | 1,553,510,887.29 | 1,636,434,285.69 | 1,912,895,613.76 |
| 非流动资产: | | | | |
| 长期股权投资 | 977,482.54 | 1,323,368.4 | 1,666,588.47 | 1,993,641.32 |
| 其他非流动金融资产 | 217,546,338.44 | 212,426,497.72 | 214,883,963.83 | 213,536,228.47 |
| 投资性房地产 | 26,670,044.29 | 26,997,804.79 | 27,325,565.29 | 27,653,325.79 |
| 固定资产 | 7,387,645,692.22 | 7,539,482,617 | 7,693,769,395.71 | 7,855,619,208.24 |
| 在建工程 | 258,247,579.31 | 248,584,518.49 | 242,980,935.85 | 209,069,389.67 |
| 无形资产 | 717,865,650.24 | 728,172,168.14 | 737,007,868.31 | 747,032,790.57 |
| 长期待摊费用 | 43,446,524.01 | 46,846,299.27 | 48,288,196.96 | 51,823,916.28 |
| 递延所得税资产 | 88,431,870.68 | 88,381,466.76 | 88,220,332.85 | 88,280,088.54 |
| 其他非流动资产 | 351,659,380.15 | 301,074,433.75 | 221,505,067.92 | 213,231,609.13 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 9,092,490,561.88 | 9,193,289,174.32 | 9,275,647,915.19 | 9,408,240,198.01 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,554,066,876.37 | 10,746,800,061.61 | 10,912,082,200.88 | 11,321,135,811.77 |
| 流动负债: | | | | |
| 短期借款 | 617,504,881.56 | 527,905,355.34 | 468,123,483.33 | 604,542,709.1 |
| 应付票据及应付账款 | 1,862,914,735.93 | 1,965,706,063.27 | 2,049,464,001.54 | 2,118,340,968.31 |
| 应付账款 | 1,862,914,735.93 | 1,965,706,063.27 | 2,049,464,001.54 | 2,118,340,968.31 |
| 预收款项 | 259,105.2 | 365,259.92 | 310,384.98 | 312,678.54 |
| 合同负债 | 218,476,442.86 | 221,256,370.82 | 219,853,391.24 | 215,306,780.17 |
| 应付职工薪酬 | 209,103,355.43 | 173,635,357.51 | 146,320,139.18 | 238,162,360.51 |
| 应交税费 | 26,033,207.34 | 26,713,828.8 | 24,839,713 | 27,525,442.31 |
| 其他应付款合计 | 239,438,093.33 | 203,733,753.77 | 207,456,854.08 | 216,749,831.47 |
| 应付股利 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 |
| 一年内到期的非流动负债 | 757,592,177.59 | 788,183,123.82 | 718,456,280.41 | 694,886,415.59 |
| 其他流动负债 | 11,257.92 | 10,840.79 | 10,904.05 | 10,974.39 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,931,333,257.16 | 3,907,509,954.04 | 3,834,835,151.81 | 4,115,838,160.39 |
| 非流动负债: | | | | |
| 长期借款 | 3,130,250,685.58 | 3,283,518,352.22 | 3,372,567,364.42 | 3,375,600,031.06 |
| 长期应付款 | 99,597 | 99,597 | 99,597 | 99,597 |
| 预计负债 | 7,540,000 | 7,568,200 | 6,043,516.52 | 7,617,237.95 |
| 递延收益 | 4,517,308.85 | 3,933,486.6 | 4,079,314.52 | 4,090,093.43 |
| 递延所得税负债 | 1,800,000 | 1,800,000 | 1,800,000 | 1,800,000 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,144,207,591.43 | 3,296,919,635.82 | 3,384,589,792.46 | 3,389,206,959.44 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,075,540,848.59 | 7,204,429,589.86 | 7,219,424,944.27 | 7,505,045,119.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,260,382,715 | 2,260,809,518 | 2,260,809,518 | 2,260,809,518 |
| 资本公积 | 1,059,514,188.37 | 1,059,771,528.6 | 1,055,673,463.37 | 1,047,229,797.78 |
| 减:库存股 | 129,974,045.42 | 132,261,709.5 | 74,824,565.57 | 74,824,565.57 |
| 盈余公积 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 |
| 未分配利润 | 61,991,076.4 | 100,494,216.57 | 169,187,782.95 | 274,100,060.23 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,652,616,319.1 | 3,689,515,938.42 | 3,811,548,583.5 | 3,908,017,195.19 |
| 少数股东权益 | -174,090,291.32 | -147,145,466.67 | -118,891,326.89 | -91,926,503.25 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,478,526,027.78 | 3,542,370,471.75 | 3,692,657,256.61 | 3,816,090,691.94 |
| 负债和股东权益合计 | 10,554,066,876.37 | 10,746,800,061.61 | 10,912,082,200.88 | 11,321,135,811.77 |
| 公告日期 | 2024-10-25 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |